$1.05 Billion is the total value of GENERAL AMERICAN INVESTORS CO INC's 63 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GILD | Sell | Gilead Sciences, Inc. | $37,561,000 | +9.7% | 463,600 | -4.1% | 3.56% | +2.9% |
CELG | Sell | Celgene Corporation | $22,602,000 | +5.5% | 155,000 | -6.1% | 2.14% | -1.2% |
OLED | Sell | Universal Display Corporation | $21,996,000 | +8.4% | 170,709 | -8.1% | 2.09% | +1.7% |
NNI | Sell | Nelnet, Inc. | $19,695,000 | -1.4% | 390,000 | -8.2% | 1.87% | -7.6% |
AAPL | Sell | Apple Inc. | $16,028,000 | -2.4% | 104,000 | -8.8% | 1.52% | -8.5% |
QCOM | Sell | QUALCOMM Incorporated | $15,614,000 | -17.1% | 301,200 | -11.7% | 1.48% | -22.3% |
AXP | Sell | American Express Company | $14,926,000 | -17.6% | 165,000 | -23.3% | 1.42% | -22.7% |
PFE | Sell | Pfizer Inc. | $13,595,000 | -12.2% | 380,808 | -17.4% | 1.29% | -17.7% |
MRK | Sell | Merck & Co., Inc. | $12,818,000 | -13.1% | 200,191 | -13.0% | 1.22% | -18.5% |
DEO | Sell | Diageo plc ADR | $12,316,000 | -20.3% | 93,210 | -27.7% | 1.17% | -25.3% |
CVS | Sell | CVS Health Corporation | $10,572,000 | -33.4% | 130,000 | -34.1% | 1.00% | -37.6% |
CHTR | Sell | Charter Communications, Inc. | $5,451,000 | -19.1% | 15,000 | -25.0% | 0.52% | -24.2% |
RVT | Sell | Royce Value Trust, Inc. | $2,833,000 | -2.9% | 179,416 | -10.3% | 0.27% | -8.8% |
Sell | RPC, INC. | $1,242,000 | -59.0% | 50,107 | -66.6% | 0.12% | -61.6% | |
RPRX | Sell | Repros Therapeutics Inc. | $76,000 | -68.2% | 237,504 | -54.3% | 0.01% | -70.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-10-27
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TJX Companies, Inc./The | 45 | Q2 2024 | 8.1% |
Republic Services, Inc. | 45 | Q2 2024 | 7.4% |
Microsoft Corporation | 45 | Q2 2024 | 6.6% |
Arch Capital Group Ltd. | 45 | Q2 2024 | 5.6% |
ASML Holdings N.V. Jan 340 Put | 45 | Q2 2024 | 5.5% |
Apple Inc. | 45 | Q2 2024 | 5.4% |
Berkshire Hathaway Inc. Class | 45 | Q2 2024 | 5.2% |
Everest Re Group, Ltd. | 45 | Q2 2024 | 4.4% |
Costco Wholesale Corporation | 45 | Q2 2024 | 4.0% |
Cisco Systems, Inc. | 45 | Q2 2024 | 3.2% |
View GENERAL AMERICAN INVESTORS CO INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
APPLIED DNA SCIENCES INC | February 09, 2016 | 281,408 | 0.9% |
EPOCH HOLDING CORP | January 31, 2013 | 912,562 | 3.7% |
View GENERAL AMERICAN INVESTORS CO INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-29 |
13F-HR | 2024-08-05 |
N-CSRS | 2024-08-05 |
NPORT-P | 2024-08-05 |
40-17G | 2024-07-24 |
4 | 2024-06-17 |
4 | 2024-05-30 |
4/A | 2024-05-24 |
4 | 2024-05-23 |
4 | 2024-05-23 |
View GENERAL AMERICAN INVESTORS CO INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.